August 19, 2021
Scientists on either side of the Atlantic have teamed up, through the new Oxford-Harrington Rare Disease Centre (OHC), to address unmet needs in rare disease research and deliver “major clinical impact” to patients. And now, the international collaboration between the University of Oxford, in England, and the...
Continue ReadingMay 30, 2021
THOUSAND OAKS, Calif. and SEATTLE, March 30, 2021 /PRNewswire/ -- Amgen Inc. (NASDAQ:AMGN) and Rodeo Therapeutics Corporation (Rodeo) today announced an agreement under which Amgen will acquire Rodeo, a privately held biopharmaceutical company based in Seattle that develops small-molecule therapies designed to promote... Continue Reading
March 29, 2021
NEW YORK, NY, March 29, 2021—The Rockefeller University has received supplemental grant support from the Harrington Discovery Institute to help fund the testing of a monoclonal antibody drug for the prevention and early treatment of COVID-19. The drug is the result of a collaborative research effort launched in the first... Continue Reading
March 24, 2021
2021 Harrington Prize for Innovation in Medicine Recognizes Outstanding Contributions to Immunology Cleveland, Ohio – The eighth annual Harrington Prize for Innovation in Medicine has been jointly awarded to Warren J. Leonard, MD, NHLBI, NIH Distinguished Investigator, and John J. O’Shea, MD, Scientific Director... Continue Reading
March 15, 2021
Program for physician-scientists to advance promising discoveries toward clinical trials CLEVELAND, Ohio USA – The 2022 Harrington Scholar-Innovator Award is now open and accepting Letters of Intent. The award offers inventive physician-scientists resources and expertise to advance their discoveries into medicines.... Continue Reading
March 02, 2021
The 2021 award targets epigenetics, proteostasis and other novel approaches Cleveland, Ohio – Harrington Discovery Institute at University Hospitals and the Alzheimer's Drug Discovery Foundation (ADDF) announce a joint request for proposals for the 2021 ADDF-Harrington Scholar Award. The ADDF-Harrington Scholar Award is... Continue Reading
February 18, 2021
The Advent-Harrington Impact Fund contributes to $215M close of Advent Life Sciences’ funds focused on areas of high unmet medical need CLEVELAND, OH—The transatlantic, not-for-profit medical accelerator, Harrington Discovery Institute at University Hospitals, has collaborated with leading venture investor, Advent... Continue Reading
November 10, 2020
Grant award provides MD/PhD candidates with funding and expertise to translate promising scientific discoveries into medicines Cleveland, Ohio, USA – Harrington Discovery Institute at University Hospitals and Case Western Reserve University School of Medicine have issued a call for proposals for the 2021 Harrington-MSTP... Continue Reading
October 23, 2020
Brief pharmacologic treatment one year after traumatic brain injury in mice reverses cognitive impairment. CLEVELAND — Traumatic brain injury (TBI) is a leading cause of cognitive impairment that affects millions of people worldwide. Despite growing awareness about the debilitating and lifelong progressive consequences... Continue Reading
October 14, 2020
Five scientists selected for their breakthrough discoveries with the potential to advance to clinical trials October 14, 2020, CLEVELAND, Ohio USA – The Harrington Discovery Institute® at University Hospitals in Cleveland, Ohio, and its registered charity Fund for Cures UK, Ltd., together with Morgan Stanley GIFT... Continue Reading
August 10, 2020
As novel coronavirus cases continue to increase in the United States and throughout the world, the Harrington Discovery Institute at University Hospitals, in collaboration with Morgan Stanley Global Impact Funding Trust Cures, is raising funds for research to bring an end to the COVID-19 pandemic. Officials confirm the money... Continue Reading